We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+13.74%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$155M
AUM Growth
+$14M
Cap. Flow
-$3.62M
Cap. Flow %
-2.33%
Top 10 Hldgs %
59.77%
Holding
49
New
1
Increased
1
Reduced
47
Closed

Top Sells

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$418K
2
CTSH icon
Cognizant
CTSH
+$359K
3
AAPL icon
Apple
AAPL
+$343K
4
CELG
Celgene Corp
CELG
+$204K
5
ULTA icon
Ulta Beauty
ULTA
+$197K

Sector Composition

Rank Sector Weight
1 Healthcare 32.99%
2 Consumer Discretionary 26.66%
3 Technology 23.43%
4 Communication Services 12.51%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
26
Boeing
BA
$167B
$838K 0.54%
4,736
-260
-5% -$44.3K
JNJ icon
27
Johnson & Johnson
JNJ
$641B
$715K 0.46%
5,739
-175
-3% -$20.9K
BMY icon
28
Bristol-Myers Squibb
BMY
$128B
$708K 0.46%
13,021
-1,050
-7% -$57.6K
NSC icon
29
Norfolk Southern
NSC
$77.1B
$555K 0.36%
4,960
-95
-2% -$11.1K
ABT icon
30
Abbott
ABT
$182B
$553K 0.36%
12,461
-545
-4% -$23.6K
TTSH
31
DELISTED
Tile Shop Holdings
TTSH
$545K 0.35%
28,331
-4,225
-13% -$79.1K
T icon
32
AT&T
T
$167B
$542K 0.35%
17,272
-503
-3% -$15.8K
LLY icon
33
Eli Lilly
LLY
$1.07T
$535K 0.34%
6,361
-120
-2% -$9.61K
PFE icon
34
Pfizer
PFE
$141B
$510K 0.33%
15,728
-880
-5% -$27.7K
PAYX icon
35
Paychex
PAYX
$41.1B
$493K 0.32%
8,363
-240
-3% -$14.6K
NEE icon
36
NextEra Energy
NEE
$185B
$488K 0.31%
15,216
-480
-3% -$15.1K
JPM icon
37
JPMorgan Chase
JPM
$947B
$460K 0.3%
5,232
-240
-4% -$21.2K
MRK icon
38
Merck
MRK
$323B
$439K 0.28%
7,239
-125
-2% -$7.58K
WBA
39
DELISTED
Walgreens Boots Alliance
WBA
$363K 0.23%
4,370
-371
-8% -$31.1K
NUE icon
40
Nucor
NUE
$56.4B
$334K 0.22%
5,601
-70
-1% -$4.28K
SLB icon
41
SLB Ltd
SLB
$76.5B
$328K 0.21%
4,197
-135
-3% -$11K
COST icon
42
Costco
COST
$422B
$309K 0.2%
1,840
-130
-7% -$21.8K
VZ icon
43
Verizon
VZ
$198B
$291K 0.19%
5,973
-340
-5% -$17.1K
CVX icon
44
Chevron
CVX
$378B
$250K 0.16%
2,325
-105
-4% -$11.8K
DUK icon
45
Duke Energy
DUK
$100B
$237K 0.15%
2,887
-150
-5% -$11.9K
BIVV
46
DELISTED
Bioverativ Inc. Common Stock
BIVV
$235K 0.15%
+4,311
New +$212K
ET icon
47
Energy Transfer Partners
ET
$68.5B
$209K 0.13%
10,611
-260
-2% -$4.9K
IP icon
48
International Paper
IP
$22.5B
$209K 0.13%
4,353
-185
-4% -$9.27K
TROW icon
49
T. Rowe Price
TROW
$25.5B
$209K 0.13%
3,073
-290
-9% -$20.6K

Similar funds

Bender Robert & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Bender Robert & Associates held 49 positions worth $155M, up 9.9% from $141M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q1 2017: portfolio turnover was 2%. Bender Robert & Associates opened 1 new position and made no exits, leaving the 49-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bender Robert & Associates's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 4,311 shares worth $235K.
  • Bender Robert & Associates added most to Alphabet (Google) Class C in Q1 2017, an estimated $54.1K increase.
  • Bender Robert & Associates's biggest Q1 2017 reduction was Vipshop, cutting an estimated $418K.
  • Bender Robert & Associates's ten largest holdings make up 60% of its $155M portfolio in Q1 2017.
  • Bender Robert & Associates opened 1 new position and closed 0 in Q1 2017.
  • Bender Robert & Associates's portfolio value rose 9.9% quarter-over-quarter to $155M.

Based on Bender Robert & Associates's 13F filing for Q1 2017, filed 12 May 2017.